Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Dupixent ® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in c
TARRYTOWN, N.Y. and PARIS, Aug. 30, 2021 /PRNewswire/ -- Dupixent rapidly improved symptoms after first dose, improving itch in one week and skin clearance in two weeks More than seven times as many p
5 Bigwigs to Buy on Double-Digit Returns in the Past Month
08:27am, Friday, 27'th Aug 2021
We have narrowed down our search to five U.S. corporate bigwigs that have provided more than 10% returns in the past month. These are: MRNA, REGN, AIG, CARR and NVDA.
3 Growth Stocks Near Record Highs That Are Still Worth Buying
05:55am, Friday, 27'th Aug 2021
Look for the current all-time highs to be broken.
Regeneron's (REGN) Wet AMD Study on High Dose Eylea Meets Goal
01:06pm, Wednesday, 25'th Aug 2021
Regeneron's (REGN) phase II study evaluating a higher 8-mg dose of Eylea injection in patients with wet age-related macular degeneration has met the primary safety endpoint.
Nvidia, Intuit, Regeneron: Cash-Rich Companies Are Outperforming Big This Year
10:30am, Wednesday, 25'th Aug 2021
Our theme of Cash-Rich Stocks filters for consistently profitable and growing companies within the S&P 500 that have a net cash position (total cash and investments less debt) that stands at 25% or mo
6 Must-Buy Corporate Giants As Major Indexes Hit Record High
08:26am, Wednesday, 25'th Aug 2021
We have narrowed down our search to six stocks that are members of any of the three major indexes. These are: MRNA, NVDA, TJX, AAPL, DE and REGN.
CARA Drug Wins FDA Nod for Pruritus Associated With CKD
12:59pm, Tuesday, 24'th Aug 2021
CARA gets a significant boost with FDA approval for Korsuva injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.
5 Stocks At the Forefront of the Latest S&P 500 Rally
09:55am, Tuesday, 24'th Aug 2021
The S&P 500 showed strength to start the new week and hit a new peak on a vaccine boost. This benefited the KR, REGN, TJX, ISRG, MSFT stocks.
Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular Degeneration
07:00am, Tuesday, 24'th Aug 2021
TARRYTOWN, N.Y., Aug. 24, 2021 /PRNewswire/ -- Phase 3 trials in wet AMD and diabetic macular edema fully recruited, with results expected in the second half of 2022 Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Shares: $727 Target From Benchmark
11:28pm, Monday, 23'rd Aug 2021
The shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) received a price target of $727 by Benchmark. These are the details.
Regeneron (REGN) COVID-19 Antibody Cocktail Gets CMA in the UK
01:00pm, Monday, 23'rd Aug 2021
Regeneron (REGN) gets Conditional Marketing Authorization for its antibody cocktail, casirivimab and imdevimab for COVID-19 infection in the United Kingdom.
Combat the Choppy Market With These 5 Low-Beta Stocks
10:40am, Friday, 20'th Aug 2021
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. CHWY, REGN, VSTO, RGR & CICHY are the frontrunners.
5 Stocks With High ROE to Buy Amid Fresh COVID-19 Fears
10:40am, Friday, 20'th Aug 2021
T. Rowe Price Group (TROW), KLA Corporation (KLAC), Whirlpool (WHR), CBRE Group (CBRE) and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy as coronavirus resurgence fear s
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
09:47am, Friday, 20'th Aug 2021
The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Roche Holding AG (OTC: RHHBY) to prevent and treat COVID-19. The U.K. chief m
